Cart
sales@molnova.com
Gymnoside IX
CAS No. 898827-00-4
Gymnoside IX( ——— )
Catalog No. M38828 CAS No. 898827-00-4
Gymnoside IX (compound 2) can be isolated from the methanolic extract from the tubers of Gymnadenia conopsea.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameGymnoside IX
-
NoteResearch use only, not for human use.
-
Brief DescriptionGymnoside IX (compound 2) can be isolated from the methanolic extract from the tubers of Gymnadenia conopsea.
-
DescriptionGymnoside IX (compound 2) can be isolated from the methanolic extract from the tubers of Gymnadenia conopsea.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number898827-00-4
-
Formula Weight1061.05
-
Molecular FormulaC51H64O24
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Toshio Morikawa, et al. Bioactive Constituents from Chinese Natural Medicines. XVII. Constituents with Radical Scavenging Effect and New Glucosyloxybenzyl 2-Isobutylmalates from Gymnadenia conopsea. Chem. Pharm. Bull.2006, 54, 4.
molnova catalog
related products
-
Soyasapogenol A
Soyasapogenol A shows estrogenic and hepatoprotective activities, it directly prevents apoptosis of hepatocytes, and secondly, inhibits the elevation of plasma TNF-α±, which consequently resulted in the prevention of liver damage in the concanavalin A-induced hepatitis model.
-
Biotin-Ahx-ω-Conotox...
Biotin-Ahx-ω-Conotoxin GVIA
-
Taurocholic acid
Taurocholic acid is a bile acid involved in the emulsification of fats.Taurocholic acid is cytoprotective, preventing tumor necrosis factor-alpha-induced cholangiocyte damage via a PI3K-mediated pathway.
